Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox/DMSO Instillations for Overactive Bladder
NCT00583219Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2006
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in overactive bladder (OAB) and detrusor overactivity, sponsored by Mayo Clinic. Primary endpoint: Median Number of Incontinent Episodes During 24 Hours at 3 months. Started Mar 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)detrusor overactivity
Beyond the preview
Go deeper on NCT00583219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583219.